Ghrelin raises [Ca2+]i via AMPK in hypothalamic arcuate nucleus NPY neurons

Biochemical and Biophysical Research Communications

Volumn 366, Issue 2, 2008, Pages 388-392

  Kohno, Daisuke ^a   Sone, Hideyuki ^a,b   Minokoshi, Yasuhiko ^c   Yada, Toshihiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Niigata Women's College   (Japan)

^c NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

ACC; AICAR; AMPK; Arcuate nucleus; Ca2+; Compound C; Feeding; Ghrelin; NPY

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CALCIUM; GHRELIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NEUROPEPTIDE Y; AMP ACTIVATED PROTEIN KINASE KINASE; AMP-ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARCUATE NUCLEUS; ARTICLE; CELL ISOLATION; ENZYME ACTIVITY; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROFLUOROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REGULATORY MECHANISM; SENSOR; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; METABOLISM; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ARCUATE NUCLEUS; CALCIUM; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GHRELIN; MALE; NEURONS; NEUROPEPTIDE Y; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 37449021674     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.166     Document Type: Article

References (27)

1. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
2. Date Y., Kojima M., Hosoda H., Sawaguchi A., Mondal M.S., Suganuma T., Matsukura S., Kangawa K., and Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141 (2000) 4255-4261
3. 2+ signaling in β-cells: implication in the glycemic control in rodents. Diabetes 53 (2004) 3142-3151
4. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
5. Wren A.M., Small C.J., Ward H.L., Murphy K.G., Dakin C.L., Taheri S., Kennedy A.R., Roberts G.H., Morgan D.G., Ghatei M.A., and Bloom S.R. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 (2000) 4325-4328
6. Willesen M.G., Kristensen P., and Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 70 (1999) 306-316
7. 2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 52 (2003) 948-956
8. Hardie D.G., Carling D., and Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell?. Annu. Rev. Biochem. 67 (1998) 821-855
9. Minokoshi Y., Alquier T., Furukawa N., Kim Y.B., Lee A., Xue B., Mu J., Foufelle F., Ferré P., Birnbaum M.J., Stuck B.J., and Kahn B.B. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428 (2004) 569-574
10. Mountjoy P.D., Bailey S.J., and Rutter G.A. Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activity. Diabetologia 50 (2007) 168-177
11. Claret M., Smith M.A., Batterham R.L., Selman C., Choudhury A.I., Fryer L.G., Clements M., Al-Qassab H., Heffron H., Xu A.W., Speakman J.R., Barsh G.S., Viollet B., Vaulont S., Ashford M.L., Carling D., and Withers D.J. AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neurons. J. Clin. Invest. 117 (2007) 2325-2336
12. Andersson U., Filipsson K., Abbott C.R., Woods A., Smith K., Bloom S.R., Carling D., and Small C.J. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279 (2004) 12005-12008
13. Kola B., Hubina E., Tucci S.A., Kirkham T.C., Garcia E.A., Mitchell S.E., Williams L.M., Hawley S.A., Hardie D.G., Grossman A.B., and Korbonits M. Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J. Biol. Chem. 280 (2005) 25196-25201
14. Kohno D., Nakata M., Maekawa F., Fujiwara K., Maejima Y., Kuramochi M., Shimazaki T., Okano H., Onaka T., and Yada T. Leptin suppresses ghrelin-induced activation of neuropeptide Y neurons in the arcuate nucleus via phosphatidylinositol 3-kinase- and phosphodiesterase 3-mediated pathway. Endocrinology 148 (2007) 2251-2263
15. 2+/calmodulin-dependent protein kinase kinase alpha as Snf1-activating kinases in yeast. J. Biol. Chem. 280 (2005) 21804-21809
16. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280 (2005) 29060-29066
17. 2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2 (2005) 21-33
18. Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., Frenguelli B.G., and Hardie D.G. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2 (2005) 9-19
19. Collins S.P., Reoma J.L., Gamm D.M., and Uhler M.D. LKB1, a novel serine/threonine protein kinase and potential tumour suppressor, is phosphorylated by cAMP-dependent protein kinase (PKA) and prenylated in vivo. Biochem. J. 345 (2000) 673-680
20. Yin W., Mu J., and Birnbaum M.J. Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes. J. Biol. Chem. 278 (2003) 43074-43080
21. Moule S.K., and Denton R.M. The activation of p38 MAPK by the beta-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett. 439 (1998) 287-290
22. Hutchinson D.S., Chernogubova E., Dallner O.S., Cannon B., and Bengtsson T. Beta-adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 48 (2005) 2386-2395
23. Wolfgang M.J., and Lane M.D. The role of hypothalamic malonyl-CoA in energy homeostasis. J. Biol. Chem. 281 (2006) 37265-37269
24. He W., Lam T.K., Obici S., and Rossetti L. Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat. Neurosci. 9 (2006) 227-233
25. + channel by long chain acyl-CoA. A role in modulation of pancreatic beta-cell glucose sensitivity. J. Biol. Chem. 271 (1996) 10623-10626
26. Fulceri R., Nori A., Gamberucci A., Volpe P., Giunti R., and Benedetti A. Fatty acyl-CoA esters induce calcium release from terminal cisternae of skeletal muscle. Cell Calcium 15 (1994) 109-116
27. Akamizu T., and Kangawa K. Emerging results of anticatabolic therapy with ghrelin. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 278-283